- Ph.D., Toxicology, University of Rochester, 2012
- M.S., Toxicology, University of Rochester, 2009
- B.S., Biotechnology, Rochester Institute of Technology, 2007
- Diplomate of the American Board of Toxicology (DABT)
- University of Rochester, Biomedical Engineering, Guest Instructor
- Postdoctoral Fellow Achievement Award from the Women in Toxicology Special Interest Group, Society of Toxicology, 2015
- Best Postdoctoral Abstract Award from the Mixtures Specialty Section, Society of Toxicology, 2015
- Best Poster Award, 8th Conference on Metal Toxicity & Carcinogenesis, 2014
- Inhalation and Respiratory Specialty Section Postdoctoral Award, Society of Toxicology, 2014
- William F. Neuman Award and Scholarship for exemplary scholarship and citizenship, University of Rochester, 2011
- New Investigator of the Month, American Society of Gene and Cell Therapy, 2011
- Excellence in Research Award given to the top 3 student abstracts, American Society of Gene and Cell Therapy, 2010
- Toxicology Scholar Award, given to the most promising incoming graduate student, University of Rochester, 2007-2009
- Society of Toxicology (2010-present)
- • Medical Device and Combination Product Specialty Section (Executive Committee Councilor, 2018-2020)
- • National Capital Area Chapter (Vice President/President-Elect, 2023-present)
- • Inhalation and Respiratory Specialty Section
- • Occupational and Public Health Specialty Section (postdoctoral representative, 2014-2015)
- • Molecular and Systems Biology Specialty Section
- • Women in Toxicology Special Interest Group
- • National Capital Region Chapter of SOT (2022-present)
- • Allegheny-Erie Regional Chapter of SOT (2013-2015)
- American Board of Toxicology, Diplomate (2016-present)
- ASTM International (2018-2021)
- American College of Toxicology (2016-2021)
- Women's Council on Energy and the Environment (2015-present)
- American Society of Gene and Cell Therapy (2008-2012)
- American Thoracic Society (2008-2009)
Dr. Badding is a board-certified toxicologist and specializes in the toxicological evaluation of chemical exposures and their impacts on human health. Her expertise includes risk assessments for a variety of substances and exposure scenarios, such as extractable and leachable substances from medical devices, consumer products, particulates, industrial chemicals, and pharmaceuticals.
She has extensive experience with medical device biocompatibility and assists clients with their regulatory strategy for product testing per ISO 10993 standards, including data gap analysis, chemical characterization risk assessments, biocompatibility evaluation reports, and regulatory deficiency responses. Dr. Badding also has expertise in personal care and consumer product safety and conducts exposure-based risk assessments for human health effects.
Prior to joining Exponent, Dr. Badding held the position of Associate Service Fellow at the National Institute for Occupational Safety and Health (CDC/NIOSH), where she performed laboratory research to evaluate the toxicity of particles encountered in the occupational environment. Dr. Badding received her Ph.D. in Toxicology from the University of Rochester in 2012. Her doctoral work focused on molecular mechanisms of non-viral gene therapy.
Dr. Badding is an active member of the Society of Toxicology (SOT) and Women's Council on Energy, and the Environment (WCEE), and a past member of ASTM International, the American College of Toxicology (ACT), the American Society of Gene and Cell Therapy (ASGCT), and the American Thoracic Society (ATS).